PUBLISHER: The Business Research Company | PRODUCT CODE: 1939302
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939302
Automated analyzers are laboratory machines that perform repetitive analytical tests with minimal human involvement. They increase productivity by processing large numbers of samples quickly and accurately and are widely used in clinical, chemical, and hematology testing.
The main types of automated analyzers include biochemistry analyzers, immuno-based analyzers, hematology analyzers, and others. Biochemistry analyzers are laboratory systems used to determine the concentration of various biochemical components in biological samples for diagnostic and research applications. They process sample types such as blood, urine, serum, plasma, and others. These analyzers are utilized in applications including drug discovery, genomics, proteomics, bioanalysis, clinical diagnostics, and more, and are used by end users such as hospitals and clinics, diagnostic laboratories, pharmaceutical companies, biotechnology firms, and others.
Tariffs have influenced the automated analyzers market by increasing the cost of imported components such as sensors, microfluidic chips, and precision electronics. Segments including hematology and immuno-based analyzers are particularly impacted, with regions like Asia-Pacific and Europe facing higher import duties. This has raised production costs and affected pricing for end users such as hospitals and diagnostic labs. Positively, tariffs are encouraging local manufacturing, investment in domestic supply chains, and innovation in cost-efficient analyzer solutions.
The automated analyzers market research report is one of a series of new reports from The Business Research Company that provides automated analyzers market statistics, including automated analyzers industry global market size, regional shares, competitors with a automated analyzers market share, detailed automated analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated analyzers industry. This automated analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The automated analyzers market size has grown strongly in recent years. It will grow from $5.39 billion in 2025 to $5.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to manual and semi-automated testing methods, limited laboratory workforce efficiency, increasing clinical testing volumes, growth of diagnostic laboratories, reliance on conventional analyzers.
The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancement in fully automated analyzers, integration with ai and big data analytics, rising demand for rapid diagnostics, expansion of genomics and proteomics research, adoption of point-of-care testing solutions. Major trends in the forecast period include increasing adoption of automated laboratory systems, rising demand for high-throughput sample processing, integration of multi-functional analyzers in labs, growth in clinical diagnostics and research applications, enhanced accuracy and standardization in analytical testing.
The rising prevalence of chronic diseases is anticipated to drive the growth of the automated analyzers market in the coming years. The prevalence of chronic diseases is increasing due to aging populations, unhealthy lifestyle patterns, and growing urbanization worldwide. Automated analyzers are utilized in chronic disease management to provide efficient and accurate diagnostic testing, supporting early detection, continuous monitoring, and treatment of conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to a report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million individuals in the UK were living with chronic kidney disease, accounting for more than 10% of the population. Of these, 3.25 million people were in advanced stages of the disease, while an additional 3.9 million were in the early stages. By 2033, the number of people affected by chronic kidney disease is projected to increase to 7.61 million. Therefore, the growing prevalence of chronic diseases is contributing to the growth of the automated analyzers market.
Leading companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to improve efficiency, accuracy, and testing throughput in diagnostic laboratories. Automated clinical chemistry analyzers are advanced laboratory instruments designed to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, thereby improving operational efficiency and diagnostic accuracy. For example, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, representing a significant advancement in automated clinical chemistry testing. Featuring more than 120 high-quality assays, the analyzer is designed to enhance the capabilities of satellite and independent community hospital laboratories. It integrates advanced automation, streamlined workflows, and standardized reagents to increase testing efficiency and support clinical decision-making while complementing central hub laboratories within hub-and-spoke healthcare systems.
In April 2024, Valmet, a Finland-based technology company, acquired the process gas chromatography business from Siemens Healthineers AG for $113.05 million. This acquisition supports Valmet's strategy to strengthen its automation segment and enhance its process automation capabilities, particularly in gas chromatography and process analyzer systems. The acquired business will be integrated into Valmet's automation systems division under a newly established unit focused on analyzer products and integration, further reinforcing its position in this area. Siemens Healthineers AG is a Germany-based engineering and manufacturing company specializing in automated analyzers.
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMerieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the automated analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The automated analyzers market consists of sales of biochemistry analyzers, hematology analyzers, immunoassay analyzers, blood gas analyzers, and molecular analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automated Analyzers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses automated analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for automated analyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated analyzers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.